The age-related loss of muscle mass and/or strength and performance, sarcopenia, has been associated with geriatric syndromes, morbidity and mortality. Although sarcopenia has been researched for many years, currently there is a lack of consensus on its definition. Some studies define sarcopenia as low muscle mass alone, whereas other studies have recently combined low muscle mass, strength and physical performance suggested by the European Working Group on Sarcopenia in Older People, as well as the Asian Working Group for Sarcopenia. The arbitrary use of various available sarcopenia definitions within the literature can cause discrepancies in the prevalence and associated risk factors. The application of population-specific cut-off values in any sample population can be problematic, particularly among different ethnicities. Using commonly used cut-off points to define sarcopenia, including solely muscle mass and combined definitions, on a community-dwelling elderly Japanese population, the prevalence of sarcopenia ranged from 2.5 to 28.0% in men and 2.3 to 11.7% in women, with muscle mass measured by dual-energy X-ray absorptiometry, and 7.1-98.0% in men and 19.8-88.0% in women measured by bioelectrical impedance analysis. Body mass index was the most prominent related factor for sarcopenia across the definitions in this Japanese sample. However, other associated hematological and chronic condition factors varied depending on the definition.
Introduction
Sarcopenia, a term proposed by Rosenburg in 1989 referring to the age-related decline in lean body mass, has become a relatively well-known condition among researchers and physicians. 1 Many investigators have attempted to clarify and establish a definition for the estimation of sarcopenia in older adults, as there is still a lack of consensus on components for the diagnosis of sarcopenia and the corresponding cut-off values. [2] [3] [4] [5] [6] [7] [8] While some investigators maintain that sarcopenia should be characterized solely on muscle mass, since the publication of the European Working Group on Sarcopenia in Older People (EWGSOP) definition, more studies have used the combined definition of muscle mass, strength and performance to define sarcopenia. 9 The issue then, is that the reported prevalence of sarcopenia, or any outcome, varies depending on the definition used. [10] [11] [12] [13] Furthermore, the differences in cut-off values used for the definition can also greatly affect the outcome of the results depending on the population on which said cut-off value is applied. 2, 6, 7, 10 The different definitions of sarcopenia and their corresponding cut-off points might also have an effect on the risk factors associated with sarcopenia, which is an area that has not yet been explored. Understanding these risk factors can potentially assist in identifying early markers for sarcopenia prevention.
The purpose of the present review was to determine the differences in prevalence and factors associated with sarcopenia based on different definitions found in the literature, and to investigate how different sarcopenia definitions affect prevalence and associated factors when applied to a population of community-dwelling Japanese older adults.
Criteria for sarcopenia diagnosis and cut-off points

Muscle mass
The loss of muscle mass and increase in fat mass with aging has been well established in numerous studies. [14] [15] [16] [17] [18] The age-related loss of much mass is strongly associated with impaired mobility, greater morbidity and mortality, 7, 19, 20 and is a principal component in the causal pathway leading to frailty. 21 Therefore, the proper measurement and evaluation of muscle mass in older adults is extremely important.
The most widely used muscle mass cut-off points are those suggested by Baumgartner et al., which used skeletal muscle mass index cut-off points two standard deviations below the mean of a young reference group measured by dual x-ray absorptiometry (DXA), 7.26 kg/m 2 for men and 5.45 kg/m 2 for women. 2 As seen in Table 1 , several methods and cut-off points have been used, although many follow Baumgartner's example. The range of cut-off values shown in Table 1 for skeletal muscle index (SMI) or appendicular skeletal muscle mass adjusted by height, was 5.72-8.81 kg/m 2 in men and 4.23-7.36 kg/m 2 in women measured by DXA. [2] [3] [4] [5] [6] 10, 11, 14, 15, [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] In addition, although the golden standard method of measurement is dual DXA, bioelectrical impedance analysis (BIA) has also been used, as the method is convenient and cost-effective, making it a more desirable and perhaps appropriate method for large-scale population studies. The range of cut-off values for BIA measurements of muscle mass were 7.00-8.87 kg/m 2 in men and 5.75-6.42 kg/m 2 in women, which are smaller ranges as the number of studies are fewer relative to those using DXA. 7, 8, 12, 19, 31, 37, 38 It is not uncommon to witness these previously established cut-off points applied to various populations and samples in the literature. However, whether these population-specific cut-points should be used for any sample is questionable.
Muscle strength
Loss of muscle strength can lead to a number of major geriatric syndromes in addition to sarcopenia including frailty, mobility impairment and falls. 20, 21, 39, 44 Low muscle strength is an important public health issue, as it has been associated with poor future health outcomes, and some researchers insist that muscle quality and functionality might be more vital within the elderly population. 39, 41, 44, 48, 49 Generally, upper extremity strength is measured using hand grip strength, 20, 39, 50 and knee flexion or extension is used for lower extremity strength assessments. 37, 41 However, leg strength measurements might not be practical for large population studies or in clinical practice, as the equipment can be quite large and inconvenient, and the participants often require practice trials for accurate measurements. Therefore, grip strength is most often used in trials not only for the simplicity, reliability and affordability, but also because grip strength is a valid predictor of physical disability and mobility limitation. Grip strength cut-off points from the literature range from 26.0 to 37.0 kg in men and 18.0 to 21.0 kg in women. 9, 13, [19] [20] [21] 31, 35, 38, 39 One study suggested adjusting the cut-off values of grip strength based on body mass index (BMI). 21 Other measures of muscle strength included isokinetic knee extension torque and knee extension strength; however, these are not used as frequently (cut-off values summarized in Table 1) . 40, 41, 48, 51 
Physical performance
Among the commonly used available physical performance measures including the Short Physical Performance Battery, usual walking speed, 6-min walk test, timed get-up & go test and the stair climb power test, [52] [53] [54] usual walking speed is quick, inexpensive and a reliable measurement of physical function that can be easily implemented in clinical settings. 55 The predictive values of usual walking speed measurements for major health-related outcomes have been well established in the literature. 42, 43, 55 Determining the cut-off value for walking speed necessary to maintain a healthy, independent lifestyle is very important, which several researchers have investigated ( Table 1) .
The cut-point of gait speed ranged from 0.65 to 1.22 m/s. 9, [19] [20] [21] 31, 38, [41] [42] [43] [45] [46] [47] 55 Many of the studies found provided the same cut-off value for men and women, which does not take into account the likely height differences between the sexes. Fried et al. stratified walking speed by sex and height using the slowest 20% of a 15-ft walk as a cut-point. 21 The cut-points converted into m/s were 0.65 m/s for men ≤173 cm and women ≤159 cm, and 0.76 m/s for men >173 cm and women >159 cm.
Working definition of sarcopenia
The term sarcopenia was originally defined as the agerelated loss of muscle mass.
1 Several cut-off points have been used to define sarcopenia based on muscle mass alone. The definition proposed by Baumgartner is the most commonly used definition of sarcopenia based on height-adjusted skeletal muscle mass measured by DXA. 2 Newman suggested a definition with similar cutoff values (7.23 kg/m 2 for men and 5.67 kg/m 2 for women) measured by DXA, defining sarcopenia as those whose muscle mass was in the lowest 20% of the In 2000, Janssen developed and published predictive equations for estimating skeletal muscle mass using BIA, 56 which has since been referred to by many researchers using BIA to define sarcopenia. 8 In 2010, the EWGSOP developed a practical clinical definition and consensus diagnostic criteria for agerelated sarcopenia combining muscle mass, strength and physical performance. 9 As Manini and Clark summarized, muscle mass alone was not associated with mortality, and muscle strength is a crucial factor in the determination of physical disability and mortality. 58 The combined definition, which includes muscle mass and strength, as well as performance, might be more relevant for investigating the effects of sarcopenia on older adults. Based on the EWGSOP algorithm, walking speed below or equaling 0.8 m/s would be the first step in screening sarcopenic people. Followed by measures of muscle strength and muscle mass.
After the publication of the EWGSOP definition of sarcopenia in 2010, many investigators have applied this definition, even within trials studying populations of different ethnicities. Chen et al. summarized the Asian Working Group for Sarcopenia (AWGS), as Asian populations differ from Caucasians in ethnicity, adiposity, size and lifestyle, and the use of previous definitions obtained from varying ethnicities can be inappropriate. 31 The authors reported that a cohort effect might be observed in the use of a cut-off point derived from a young Asian population, as younger people lead a more Westernized lifestyle compared with the older generation, who most likely would have lived a more traditional lifestyle. Regardless, the AWGS recommended the traditionally used two standard deviations below the mean muscle mass of a young reference group or the lowest quintile for cut-off determination. The recommended cut-off value for height-adjusted skeletal muscle were 7.0 kg/m 2 in men and 5.4 kg/m 2 in women using DXA, and 7.0 kg/m 2 in men and 5.7 kg/m 2 in women measured by BIA. 31 Chen et al. specifically suggested the use of height-adjusted skeletal muscle mass, although research has shown that this method of measurement can underestimate the prevalence sarcopenia in Korean and Chinese populations. 15, 32 The AWGS definition of sarcopenia further suggested low handgrip strength (<26 kg for men and <18 kg for women) in addition to muscle mass to screen for sarcopenia. A walking speed of ≤0.8 m/s was recommended as the cut-off for low physical performance in Asian people. Researchers should be aware and careful of the use of previous cut-off points, as they could have an effect on the prevalence rates of sarcopenia, as well as possible risk factors.
Risk factors of sarcopenia components
Muscle mass
Investigation into the risk factors and associated factors of muscle mass decline has been ongoing for several decades. Many of the risk factors assessed for declines in muscle mass, summarized in Table 2 , include chronic conditions, such as diabetes, heart disease and hyperlipidemia; arterial stiffness, malnutrition and hematological factors. 57, 59, 60 Several hematological components have been linked to the loss of muscle mass, such as high creatinine, and high albumin concentration had protective effects. 57, 61 BMI and inflammation have also been significantly associated with muscle mass loss.
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Muscle strength
Factors associated with muscle strength loss have also been investigated. Similar to muscle mass, the literature describes hematological factors including total freetestosterone, insulin-like growth factor-1, high parathyroid hormone, hemoglobin, low 25-hydroxy vitamin D and low serum albumin to be linked to grip strength decline in longitudinal studies. 35, 62, 63 One study by Stenholm et al. found that high concentrations of interleukin-6 and interleukin-1RA, and low levels of dehydroepiandrosterone sulfate were predictors of muscle strength loss over 22 years. 66 Muscle strength loss has been associated with many chronic conditions and lifestyle factors, such as back pain, diabetes, cardiovascular disease, chronic kidney disease, hypertension, asthma, cognitive function, use of calcium channel blockers, caffeine intake, excess bodyweight, stress and smoking. 57, 64, 65, 67, 68, 76 
Walking ability
Detailed study into hematological factors linked to declines in walking ability are more limited, and although walking speed decline has been studied extensively, few studies exist that have investigated blood component risk factors. In a recent letter to the editor of the Journal of the American Geriatrics Society, Onuoha outlined that red blood cell indices (red blood cell count, hematocrit, white blood cell count) were associated with gait rhythm, but not speed. 77 The author suggested that hematological mechanisms might cause disturbances in Interleukin-6 was also associated with walking ability, being one of the hematological factors associated across all the components of sarcopenia. 70 Reports have found that walking speed declines are associated with strength, balance, fear of falling, sensory difficulties, cardiovascular disease, diabetes, rheumatoid arthritis, global function, verbal memory and executive function (Table 2) . 51, 57, [71] [72] [73] 
Risk factors of sarcopenia
Sarcopenia is a systemic condition, and as such, the risk factors reported vary greatly. Age and BMI are evident risk factors for sarcopenia. Landi et al. found that sarcopenia was more likely seen in men, 78 whereas Yu et al. reported that the female sex was a risk factor for sarcopenia (Table 3) . 83 Perhaps the difference in ethnicity between the populations might explain the conflicting results. Greater calf circumference has been reported to be protective against sarcopenia, whereas slow timed up & go test was associated with sarcopenia development longitudinally. 57 One investigation showed that higher education increased the likelihood of sarcopenia. 84 Chewing ability has also been reported to be associated with sarcopenia defined by the AWGS definition. 85 Murakami et al. state that while relationships between muscle strength, physical function and chewing ability have been reported previously, the association between muscle mass and chewing ability had not, and further suggested that the changes in general muscle mass and muscle mass related to chewing ability might have been the reason for the notable relationship between chewing ability in the study. 85 More detailed investigation into the causal relationship between sarcopenia and chewing-related muscle function decline are required.
Researchers have sought to identify blood biomarkers for sarcopenia. Currently in the literature, the associated hematological factors include low 25-hydroxyvitamin D, insulin-like growth factor 1, albumin and testosterone, as well as high gamma-glutamyl transferase and cystatin C (Table 3) . 22, 35, 57, 62, [79] [80] [81] 84, 86 Several chronic conditions and lifestyle factors have also been associated with sarcopenia. As summarized in Table 3 , older adults with high blood pressure, instrumental activities of daily living impairment, chronic obstructive pulmonary disease, chronic kidney disease, hyperlipidemia, osteoporosis and stroke are at risk for sarcopenia. 57, 80, 82, 83, 87 Furthermore, BMI, pain, being overweight, lacking exercise (sedentariness), and high fat and protein intake also increase the likelihood of being sarcopenic.
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Comparison of sarcopenia prevalence and risk factors associated with sarcopenia based on different suggested definitions
The literature is inconsistent in the application of sarcopenia definitions using previously established muscle mass cut-off points or the EWGSOP definition, which combines muscle mass, strength and physical performance. Some studies have examined the differences in prevalence rates using different sarcopenia definitions; however, there are few studies, if any, that investigate both sarcopenia prevalence and associated risk factors with differing definitions in a sample population. 3, 10, 11, 15, 30, 32, 33 The prevalence of sarcopenia was determined in a sample of 1464 community-dwelling Japanese elderly men (n = 246) and women (n = 1218, mean age men 74.3 ± 5.17 years; women 79.9 ± 4.43 years) using each definition described in the previous section ( Table 4) . The data analyzed in the present review was obtained using protocol that has been approved by the Tokyo Metropolitan Institute of Gerontology Ethics Committee, and all participants gave informed consent. As seen in Table 4 , sarcopenia prevalence in this sample varied greatly depending on the definition used. Within the DXA-measured definitions, the prevalence ranged from 2.5 to 28.0% in men and 2.3 to 11.7% in women, which is not unlike previously reported prevalence values.
The BIA-measured definitions, however, resulted in sarcopenia prevalence ranging from 7.1 to 98.0% in men and 19.8 to 88.0% in women. These largely wide ranges within the same population are problematic, as it brings into question the results of the existing studies, and the sarcopenia prevalence we understand as a research community. In the existing literature, some studies refer to these previously established definitions of sarcopenia without providing reasoning beyond its common use. Ideally, each trial should determine population-specific cut-off points; however, this would be very expensive and impractical. Large populationbased studies are required for Japanese people to establish appropriate cut-off values for Japanese older adults. The seemingly arbitrary use of published cut-off values can affect the resulting prevalence rates of sarcopenia and associated factors.
We investigated the risk factors of sarcopenia in the same Japanese community-dwelling population using multiple step-wise logistic regressions. Table 5 shows that the risk factors associated with sarcopenia varied depending on the definition for sarcopenia assessment used.
BMI was predominantly associated with sarcopenia in men and women across most definitions, where greater BMI was inversely associated with the likelihood of Based on the EWGSOP and AWGS definitions of sarcopenia using both DXA and BIA, falls were a significant risk factor for sarcopenia in women (Table 5) . Similarly, high albumin levels had protective effects in the EWGSOP (OR 0.31, 95% CI 0.16-0.60) and AWGS (OR 0.28, 95% CI 0.13-0.61) definitions, although only using BIA. Other risk factors for sarcopenia in women included knee OA, TG levels, high-density lipoprotein cholesterol, creatinine, diabetes and hyperlipidemia.
The results presented in Table 5 show disparities in risk factors of sarcopenia vary greatly depending on the definition used to define sarcopenia in the same sample population. BMI was the only factor associated with sarcopenia across all definitions within the Japanese population studied, and a predominant risk factor for sarcopenia in previous studies (Table 5) . Herein lies the problem with the many available definitions currently used in the literature. Without a clear consensus, the risk factors of sarcopenia differ, not only with varying definitions, but also with methods of measurement; that is, DXA or BIA. The discrepancies in prevalences and associated factors of sarcopenia in the existing literature can negatively affect the understanding of sarcopenia within the research community.
Conclusion
In summary, the inconsistencies in sarcopenia definitions, cut-off values and risk factors are apparent within the literature. Ideally, cut-off values should detect people with risk factors, and using cut-off values obtained from a vastly different population should be avoided. The application of the different sarcopenia definitions further shows that sarcopenia prevalence and risk factors vary greatly depending on the definition. Further studies and discussions are necessary in order to confirm the discrepancies in prevalence and particular risk factors, and develop a consensus definition or cut-off points for sarcopenia in Japanese older adults.
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